Status:
COMPLETED
TODAY2 Phase 2 Follow-up
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
National Eye Institute (NEI)
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
15+ years
Brief Summary
The primary objective of T2P2 is to track the progression of T2D and related comorbidities and complications in the TODAY cohort as they transition to young adulthood. We hypothesize that: * Youth-on...
Eligibility Criteria
Inclusion
- Participated in TODAY clinical trial.
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 17 2020
Estimated Enrollment :
517 Patients enrolled
Trial Details
Trial ID
NCT02310724
Start Date
March 1 2014
End Date
January 17 2020
Last Update
August 5 2021
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027
2
University of Colorado Denver Children's Hospital
Aurora, Colorado, United States, 80045
3
Yale University School of Medicine Department of Pediatrics
New Haven, Connecticut, United States, 06520
4
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114